Does BIMEKIZUMAB Cause Psoriatic arthropathy? 615 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 615 reports of Psoriatic arthropathy have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 25.0% of all adverse event reports for BIMEKIZUMAB.
615
Reports of Psoriatic arthropathy with BIMEKIZUMAB
25.0%
of all BIMEKIZUMAB reports
1
Deaths
27
Hospitalizations
How Dangerous Is Psoriatic arthropathy From BIMEKIZUMAB?
Of the 615 reports, 1 (0.2%) resulted in death, 27 (4.4%) required hospitalization.
Is Psoriatic arthropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BIMEKIZUMAB. However, 615 reports have been filed with the FAERS database.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Oral candidiasis (146)
Fatigue (138)
Therapy interrupted (138)
Pneumonia (118)
What Other Drugs Cause Psoriatic arthropathy?
SECUKINUMAB (8,900)
ADALIMUMAB (8,148)
METHOTREXATE (7,167)
APREMILAST (7,035)
ETANERCEPT (6,518)
CERTOLIZUMAB PEGOL (5,798)
LEFLUNOMIDE (4,703)
INFLIXIMAB (4,238)
GOLIMUMAB (4,101)
SULFASALAZINE (3,961)
Which BIMEKIZUMAB Alternatives Have Lower Psoriatic arthropathy Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN